Oral Administration of N-Acetyl-seryl-aspartyl-lysyl-proline Ameliorates Kidney Disease in Both Type 1 and Type 2 Diabetic Mice via a Therapeutic Regimen. - Nitta, Kyoko; Shi, Sen; Nagai, Takako; Kanasaki, Megumi; Kitada, Munehiro; Srivastava, Swayam Prakash; Haneda, Masakazu; Kanasaki, Keizo; Koya, Daisuke (BioMed Research International, 2016)